Fortis Healthcare share news, announcements and annual reports
NSE: FORTISBSE: 532843Healthcare ServicesMid Cap
Fortis Healthcare Limited · Formerly Fortis Healthcare (India) · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2007
Last close ₹759.50up ₹23.00 (3.12%)BSE ₹758.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹736.50.
28 Oct: open ₹734.90, high ₹762.90, low ₹726.85
52-week range of traded prices to 28 Oct 2026
₹704.95Low, 23 Oct 2026₹1,067.70High, 28 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,339 Cr156th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 54.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.13%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.28
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 14,44,49645.3% delivered
Fortis Healthcare disputes and clarifications
46 filed, newest first.
Jan 2026
Dec 2025
30 Dec · Legal
30 Dec · Legal
30 Dec · Legal
Apr 2025
Sep 2022
15 Sep · Legal
The exchange asked on 14 Sep 2022
May 2022
Apr 2022
Nov 2018
Aug 2018
Jul 2018
12 Jul · Legal
Exchange has sought clarification from Fortis Healthcare Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
Jun 2018
29 Jun · Legal
Exchange has sought clarification from the Company with respect to news item captioned- Sebi orders audit of Fortis Healthcare, SFIO suspects fraud In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
May 2018
23 May · Legal
Exchange has sought clarification from the Company with respect to news item captioned- "SEBI probes insider trading violation, other regulatory lapses at Fortis Health" In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
Apr 2018
17 Apr · Legal
Exchange has sought clarification from the Company with respect to news item captioned- "Fortis raises Rs 150 crore bridge loan in bid to stave off insolvency" In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.16 Apr · Legal
Exchange has sought clarification from the Company with respect to news item captionedMalaysia's IHH says Fortis board declines to engage on takeover offerIn this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.13 Apr · Legal
Exchange has sought clarification from the Company with respect to news item captioned- "IHH to launch counter bid to buy Fortis" In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
Mar 2018
Feb 2018
27 Feb · Legal
Exchange has sought clarification from the Company with respect to news item captioned "Delhi HC orders seizure of Singh brothers assets. In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited19 Feb · Legal
Exchange has sought clarification from the Company with respect to news item captioned "SFIO probe against Fortis and Religare" In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.12 Feb · Legal
Exchange has sought clarification from Fortis Healthcare Limited with respect to announcement dated 13-Jan-2018, regarding "Disclosure under Regulation 30 and letter Ref. No. FHL/SEC/STEX/RR/2017-18 dated November 14, 2017 wherein the Company had informed about entering into a term sheet ( Term Sheet) in relation to the proposed acquisition by the Company and/or its subsidiaries of the equity and financial securities, in the relevant Indian entities under RHT Health Trust (RHT) of, International Hospital Limited and Fortis Health Management Limited (and consequentially Escorts Heart and Super Speciality Hospital Limited, Hospitalia Eastern Private Limited and Fortis Hospotel Limited) from the wholly-owned subsidiaries of RHT ( Proposed Transaction). As per the agreed Term Sheet, the parties had entered into an exclusivity period for 60 days, commencing from the date of the Term Sheet with a view to executing definitive agreements for the Proposed Transaction. The said period of 60 days expires on January 12, 2018. It is hereby further informed that, the parties to the Term Sheet have on January 12, 2018, mutually agreed to extend the Exclusivity Period by an additional period of 30 days from January 12, 2018. This is in order to facilitate the continued negotiations and finalisation of the Definitive Agreements in relation to the Proposed Transaction. In this regard you are require to update on said proposed acquisition ASAP.The response of the Company is awaited.9 Feb · Legal
Exchange has sought clarification from the Company with respect to news item captioned Looks like there is lack of Corporate Governance in Fortis, Deloitte refuses to certify Fortis Q2 results, Singh Brothers said to have taken out $78M from the Firm. In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
Jan 2018
31 Jan · Legal
Exchange has sought clarification from the Company with respect to news item captioned "Daiichi wins Rs 3,500 crore arbitration case against Singh brothers in Delhi High Court " In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
Apr 2017
27 Apr · Legal
Exchange has sought clarification from the Company with respect to news item captioned "3 hospitals recycled one-use angio medical devices, finds FDA". In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
Sep 2015
16 Sep · Legal
Exchange has sought clarification from Fortis Healthcare Limited with respect to recent news item captioned "Fortis to exit Pathology business in Dubai". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.
Aug 2014
Jun 2013
Apr 2009
2 Apr · Legal
Clarification for news item appearing in a newspaper dated March 31, 2009 titled "Fortis Closes in on Wockhardt arm". The Company clarifies that "As a strategy, the Company is continuously evaluating acquisition opportunities to expand its network of hospitals. However, at this stage, the Company has not entered into any definitive agreement for any acquisition. As such, the news report is speculative in nature".